
Identification
CAS Number
40732-48-7
Name
Guanosine3′,5′-cyclicmonophosphatesodiumsalt
Synonyms
(4aR,6R,7R,7aS) 2-Oxyde de 6-(2-amino-6-oxo-3,6-dihydro-9H-purin-9-yl)-7-hydroxytétrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-2-olate et de sodium [French] [ACD/IUPAC Name]
255-056-0 [EINECS]
3′,5′-cGMP-Na
3′,5′-Cyclic GMP monosodium salt
40732-48-7 [RN]
6H-Purin-6-one, 2-amino-3,9-dihydro-9-[(4aR,6R,7R,7aS)-tetrahydro-2,7-dihydroxy-2-oxido-4H-furo[3,2-d]-1,3,2-dioxaphosphorin-6-yl]-, sodium salt (1:1) [ACD/Index Name]
cGMP
Cyclic GMP
Cyclic GMP sodium salt
Guanosine 3′,5′-cyclophosphate monosodium salt
MFCD00038424 [MDL number]
Natrium-(4aR,6R,7R,7aS)-6-(2-amino-6-oxo-3,6-dihydro-9H-purin-9-yl)-7-hydroxytetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-2-olat-2-oxid [German] [ACD/IUPAC Name]
Sodium (4aR,6R,7R,7aS)-6-(2-amino-6-oxo-3,6-dihydro-9H-purin-9-yl)-7-hydroxytetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-2-olate 2-oxide [ACD/IUPAC Name]
sodium 3′,5′-cyclic gmp anion
SODIUM GUANOSINE CYCLIC MONOPHOSPHATE
,5ʹ
[40732-48-7] [RN]
3′,5′-cyclic Guanosine monophosphate
3′,5′-cGMP-Na
3′,5′-Cyclic GMP monosodium salt
cyclic 3′,?5′-?(hydrogen phosphate) guanosine, monosodium salt
Cyclic GMP sodium
Cyclic GMP, G-3,5-MP, cGMP, Na
-cyclic Monophosphate, Sodium Salt – CAS 40732-48-7 – Calbiochem
Guanosine 3ʹ
Guanosine 3ʹ,5ʹ-cyclic Monophosphate, Sodium Salt – CAS 40732-48-7 – Calbiochem
Guanosine 3′,5′-Cyclic Monophosphate Sodium Salt
Guanosine 3’5’-cyclic Monophosphate, Sodium Salt
Guanosine 3′,5′-cyclic monophosphate sodium salt
Guanosine 3′,5′-cyclophosphate monosodium salt
Guanosine 3’5′-cyclic Monophosphate, Sodium Salt
Guanosine-3′:5′-cyclic monophosphate monosodium salt
Guanosine3:5-cyclicmonophosphatesodiumsalt
GUANOSINE3′:5′-CYCLICMONOPHOSPHATESODIUMSALT
sodium (4aR,6R,7R,7aS)-6-(2-amino-6-oxo-6,9-dihydro-1H-purin-9-yl)-7-hydroxy-2-oxo-hexahydro-2??-furo[3,2-d][1,3,2]dioxaphosphinin-2-olate
SMILES
c1nc2c(n1[C@H]3[C@@H]([C@H]4[C@H](O3)COP(=O)(O4)[O-])O)[nH]c(nc2=O)N.[Na+]
StdInChI
InChI=1S/C10H12N5O7P.Na/c11-10-13-7-4(8(17)14-10)12-2-15(7)9-5(16)6-3(21-9)1-20-23(18,19)22-6;/h2-3,5-6,9,16H,1H2,(H,18,19)(H3,11,13,14,17);/q;+1/p-1/t3-,5-,6-,9-;/m1./s1
StdInChIKey
KMPIYXNEROUNOG-GWTDSMLYSA-M
Molecular Formula
C10H11N5NaO7P
Molecular Weight
367.187
MDL Number
MFCD00038424
Properties
Appearance
White powder
Safety Data
Symbol
Signal Word
Warning
WGK Germany
3
MSDS Download
Specifications and Other Information of Our Guanosine3′,5′-cyclicmonophosphatesodiumsalt CAS 40732-48-7
Purity
99% min
Loss on Drying
≤7.0%
EmM UV-vis spectrum, dry basis PH 7.0
14.08
Shelf Life
1 year
Storage
-20℃, sealed well and away from light
Known Application
Sodium Guanosine-3′,5′-Cyclic Monophosphate (cGMP-Na) has several important applications in biochemistry, pharmacology, and biotechnology.
1. Signal Transduction Research
- cGMP acts as an intracellular second messenger, playing a critical role in various biological signal transduction processes, such as smooth muscle relaxation, vasodilation, and neural signaling.
- It is widely used to study guanylate cyclase activity and cGMP-dependent signaling pathways.
2. Pharmacological Studies
- Used to investigate the effects of drugs targeting cGMP-related pathways, such as treatments for hypertension, erectile dysfunction (e.g., mechanisms of phosphodiesterase-5 inhibitors), and cardiovascular diseases.
- Aids in new drug development and the evaluation of drug effects on cGMP-related processes.
3. Enzymology Research
- Serves as a substrate for cGMP-dependent protein kinases and phosphodiesterases, enabling studies of enzyme mechanisms and their regulatory functions.
4. Cellular and Molecular Biology
- Facilitates research on cGMP’s role in cell proliferation, differentiation, and apoptosis.
- Applied in cellular models or tissue culture experiments to explore signaling pathway regulation.
General View of Documents
Links
This product is developed by our R&D company Ulcho Biochemical Limited (http://www.ulcho.com/).
Quick Inquiry
Fill out our inquiry form and one of our experts will be in touch with you shortly.